CellularOrigins, a TTP Company, is focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies.
Created to enable therapy developers to access the technologies they want at scale, CellularOrigins’ proprietary technology provides a transformative solution for automated, sterile, fluidic interconnection, to enable cell and gene therapy manufacturing at scale without process redevelopment whilst simultaneously allowing for process innovation.
Interfacing robotics with automated sterile connection, CellularOrigins’ modular factory enables manufacturing at scale. The technology is available for the manufacture of therapies currently in late-stage development, and has the flexibility to adapt and link bioprocess equipment of the future, enabling process innovation and advancement.
TTP has more than 30 years’ experience in supporting the world’s most innovative and ambitious organisations develop new tools and technologies,. Bringing together expertise from across the life science, engineering, and robotics industries, CellularOrigins is focused on enabling developers to accelerate their therapeutics to market.